Is $Mesoblast(MESO)$ a must buy?
NOTE!
1. NFA
2. Do not open position without chart confirmation, indicators, momentum.
3. Check current shorts availability on FINTEL.io
4. Scale out and secure profits
5. Always remember shorts include dark pools.
6. Most importantly, don’t blame for your losses. I already give watchlist and stock education. The ball is on you.
7. I DO NOT give buy or sell advice
8. COH (cash on hand); AH (after hours): RTH (regular trading hours)
$Currenc Group (CURR.US)$ Despac Skyrocketed front 2 to 12.14 after hours. No PR. Either upcoming PR or pure pump. May continue tomorrow. Low float. 0 shares LTB. COH $45.6M good for 35.2 months. Wait for pullback if you play this.
$Elevai Labs (ELAB.US)$ No PR but up AH. Probably upcoming PR. Low float. 0 shares. COH $5.4M good for 14 months
$Nukkleus (NUKK.US)$ PR 12/17 Executed a controlling stake ($26M value) in Iron Dome supplier. For me this is not done. I believe the market will defy the $10M Private placement announced. Low float. 0 shares LTB. COH $1.4M- this will change after closing of private placement. This is likely this year’s Stock Santa Claus
$ParaZero Technologies (PRZO.US)$ No PR, up AH, possible sympathy play to NUKK. Low float. COH $3.4M good for 10.1 months
$The Glimpse (VRAR.US)$ No PR. Ran today. Up AH. Chart looks good Price over VWAP with EMA short term bullish. COH $1M. High risk dilution
$Scilex Holding (SCLX.US)$ PR AH 12/18 Form 4 insider buying.
$XCHG (XCH.US)$ beaten down (EV charger company) from 12 to 1.9 and up after hours. May continue rebound. Low float. 0 shares LTB. COH $41.6M
$Sacks Parente Golf (SPGC.US)$ PR AH 12/18 13G. Up AH. Microfloat. COH $8.9M good for 23.4 months
$BioAge Labs (BIOA.US)$ PR 12/18: Multi-Year Collaboration With Novartis To Discover Novel Targets For Therapies That Address Age-Related Diseases And Conditions; Novartis To Pay Up To $20M Comprising Upfront Payments And Research Funding; BioAge May Receive Up To $530M In Future Long-Term Research, Development, And Commercial Milestones. Didnt get traction today. Low float. No history of dilution. Caution on this.
$American Battery Technology (ABAT.US)$ PR 12/18: Awarded $144 Million Grant Contract From U.S. Department of Energy for Construction of Second Lithium-Ion Battery Recycling Facility. Large float. COH $12.8M good for 6.9 months
$Graphex Group (GRFX.US)$ Possible sympathy play to LITM. Graphene products company. China stock. No cash. HIGH risk for dilution.
$Foresight Autonomous (FRSX.US)$ No PR but up AH. Possible sympathy play to NUKK. Israel company. Last PR 12/9 with agreement with South Korea company. Low float. COH $6.4M good for 6.9 months
$BloomZ (BLMZ.US)$ PR 12/18: Entered into a business alliance with TechnoBlood eSports to integrate its VTuber business into the e-sports and live streaming domain. Up AH. Low float.
$Mesoblast (MESO.US)$ PR AH 12/18: FDA: Approved Ryoncil Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease in Pediatric Patients 2 Months of Age & Older. Up AH. COH $39.8M good for 9.9 months
$Trinity Biotech (TRIB.US)$ PR 12/18: Receives Early Approval From The WHO To Begin Offshore Manufacturing Of TrinScreen HIV & Uni-Gold HIV. Relatively
Low float. COH $11.5M good for 31.4 months
$CXApp (CXAI.US)$ No PR. Slightly Up AH. Low float. COH $3.7M good for 17.1 months
$Fitell (FTEL.US)$ No PR. Up AH by 45%. Dropped 80% during RTH. Possible continuation. Low float. SI 25.44%. COH. No cash. HIGH risk for dilution. Caution here.
$CEL-SCI (CVM.US)$ No PR today. Last PR 12/12: Highlighted the biological use of Multilkine for head and neck cancer. Multiline the first cancer immunotherapy to show pre-surgical tumor regression in head and neck cancer in just 3 weeks - confirmed by pathology at surgery and showed significant rates of tumor progression which from a medical standpoint is impressive. Up AH. 0 shares LTB. COH $1.7M good for 1.1 months. High risk for dilution
$Silexion Therapeutics (SLXN.US)$ PR 12/18: Collaborates With Evonik on Advanced SiRNA Formulation Development. Microfloat. CTB 399%. COH $0.4M good for 0.7 months. HIGH risk for dilution
$NOVONIX (NVX.US)$ PR AH 12/18: Joined a coalition of American graphite producers in filing a trade case against China, alleging unfair pricing practices in the export of battery-grade graphite to the U.S. Up on overnight trading.
$Sangamo Therapeutics (SGMO.US)$ PR 12/16: Roche ending development of a phase 3 gene therapy candidate for hemophilia A which benefits SGMO as SGMO has the gene therapy giroctocogene fitelparvovec for the same indication. Huge float. COH $21.8M good for 3.1 months.
$Oragenics (OGEN.US)$ No PR. Up AH with good volume. Low float. 0 shares LTB. COH $1.2M good for 1.6 months High risk for dilution
$AppTech Payments (APCX.US)$ PR 12/17: Received a $5 Million Investment From AFIOS Partners and Is Restructuring Its Board by Appointing Three New Directors. Up AH. Relatively low float. COH $1.3M good for 2.4 months. High risk for dilution.
$T2 Biosystems (TTOO.US)$ PR 12/18: Sells Four T2Dx Instruments To Existing European Distributor. Up AH. Low float. No cash. High risk for dilution.
$XChange TEC (XHG.US)$ No PR. Up AH. This is China stock so they may pump it. Caution for P&D. COH $1.5M good for 29.2 months
$DallasNews (DALN.US)$ PR 12/18: Sells North Plant Property for $43.5M. Up AH. Low float. COH $13.3M
$VSee Health (VSEE.US)$ PR 12/18: Awarded teleradiology services agreement with Premier. What makes this big is that Premier serves 2/3 of US healthcare providers. Low float. CTB 506%. COH $1.5M good for 4.8 months. High risk for dilution.
$MMTEC Inc (MTC.US)$ Post RS 12/18 China stock. Up AH. May get pumped. Caution. Relatively low float. 0 shares LTB. COH $1.2M good for 3.9 months. High risk for dilution.
$22nd Century (XXII.US)$ Post RS 12/17. Super microfloat. 0 shares LTB. COH $7.4M good for 6.7 months
$Globalstar (GSAT.US)$ PR 12/18: Announce Collaboration and Availability of Band 53 Spectrum on Hawk's Platform. No risk for dilution
$Algorhythm (RIME.US)$ PR 12/18: Wins New Pilot Program With 6th Largest Global Consumer Package Goods Company. Take note 45M shares traded today diverted to dark pool. COH $12.7M gold for 16.1 months
$WiMi Hologram Cloud (WIMI.US)$ PR 12/18: Develops New Design Solution For Simulating Quantum Computing Concepts Using FPGA. China stock. COH $10.5M
$Future FinTech (FTFT.US)$ No PR. Blockchain company. COH $2.5M goos for 1.7 months
$KULR Technology (KULR.US)$ PR 12/18. Possible continuation.
Other stocks with good PR Wednesday: $Transcode Therapeutics (RNAZ.US)$ $SatixFy Communications (SATX.US)$ $Interactive Strength (TRNR.US)$ $SmartKem (SMTK.US)$ $Cara Therapeutics (CARA.US)$ $SEALSQ Corp (LAES.US)$
*******************************************
◾️ALL Bird Flu stocks on watch
$Aethlon Medical (AEMD.US)$ COH $5.2M good for 7.9 months. Low float
$BioCryst Pharmaceuticals (BCRX.US)$ No dilution risk. Up AH
$CureVac (CVAC.US)$ No dilution risk
$GeoVax Labs (GOVX.US)$ COH $4.8M good for 2.6 months. Low float. Up AH
$Inovio Pharmaceuticals (INO.US)$ COH $90.9M good for 9.7 months
$Nanoviricides (NNVC.US)$ COH $1.6M good for 1.8 months. High dilution risk. Low float. Up AH
$China SXT Pharmaceuticals (SXTC.US)$ COH $11.4M. China low float. Up AH
$Tonix Pharmaceuticals (TNXP.US)$ COH $19.5M good for 3.8 months.Up AH
$TOMI Environmental Solutions (TOMZ.US)$ COH $400K good for 2.4 months. High dilution risk. Up AH
$Virax Biolabs (VRAX.US)$ COH $5.6M good for 7.8 months. Low float. Up AH
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.